The CCHMC PCEN Gene Expression Core (Core A) provides essential NexGen sequencing based RNA- Seq services, as well as more conventional microarray based gene expression technology. This is coupled with an integrative bioinformatics analysis capacity for investigators. Core A will provide consultation and collaboration with respect to experimental design, data generation and data analysis. Core A will facilitate planning and execution of mRNA, miRNA and total RNA (including noncoding RNA) gene expression analysis using a variety of technologies, including multiple library preparation and target amplification protocols for RNA-Seq and microarrays, using the lllumina HiSeq 2000 for NexGen analysis, and both Affymetrix and lllumina platforms for microarray analysis. In addition we offer capacity for Chip-Chip, Chip- Seq RNA splicing and promoter profiling analyses. Data from these technologies are fully interfaced to their corresponding bioinformatics analysis platforms, custom developed databases for sample and tracking, and a suite of advanced analysis softwares for DNA, genomic and transcriptomic analyses are readily accessible to the Center's investigators through a high performance computing environment Core A will dramatically enhance the ability ofthe members ofthe PCEN to make use of global gene expression technologies in their research projects. In addition the core will provide dedicated support for data analysis, collaboration, and educational activities for both established and junior investigators, as well as trainees.
Aim 1 will empower Center members by providing access to integrated state ofthe art gene expression technologies with which to apply genomics methods to accelerate molecular nephrology research.
Aim 2 will educate, assist, and iriiprove the use of global genomics approaches, infrastructure and specialized tools for the enhancement of research productivity and discovery by Center investigators.
Aim 3 will develop and disseminate specialized data sets and the use of advanced analytic techniques and/or protocols to facilitate translation of research data to accelerate basic and applied research and its translation to improved clinical care.

Public Health Relevance

Pediatric kidney diseases due to acute kidney injury, focal segmental glomerulosclerosis, and lupus nephritis contribute to an enormous major impact on the U.S. public health and a major financial burden. The Gene Expression Core ofthis Center of Excellence in Nephrology will provide critical genomic tools for miiltiple investigators to advance their studies on these three disease states to change their dismal outcomes

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center (P50)
Project #
1P50DK096418-01
Application #
8397957
Study Section
Special Emphasis Panel (ZDK1-GRB-G (M3))
Project Start
Project End
Budget Start
2012-09-21
Budget End
2013-08-31
Support Year
1
Fiscal Year
2012
Total Cost
$152,507
Indirect Cost
$52,829
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Chihanga, Tafadzwa; Ma, Qing; Nicholson, Jenna D et al. (2018) NMR spectroscopy and electron microscopy identification of metabolic and ultrastructural changes to the kidney following ischemia-reperfusion injury. Am J Physiol Renal Physiol 314:F154-F166
Greenberg, Jason H; Zappitelli, Michael; Jia, Yaqi et al. (2018) Biomarkers of AKI Progression after Pediatric Cardiac Surgery. J Am Soc Nephrol 29:1549-1556
Volovelsky, Oded; Gist, Katja M; Terrell, Tara C et al. (2018) Early postoperative measurement of fibroblast growth factor 23 predicts severe acute kidney injury in infants after cardiac surgery?. Clin Nephrol 90:165-171
Gist, Katja M; Cooper, David S; Wrona, Julia et al. (2018) Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine-Defined Acute Kidney Injury in Infants After Cardiac Surgery. Ther Drug Monit 40:186-194
Bennett, Michael R; Pyles, Olivia; Ma, Qing et al. (2018) Preoperative levels of urinary uromodulin predict acute kidney injury after pediatric cardiopulmonary bypass surgery. Pediatr Nephrol 33:521-526
Albert, Christian; Albert, Annemarie; Bellomo, Rinaldo et al. (2018) Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgery. Biomark Med 12:975-985
Basu, Rajit K; Kaddourah, Ahmad; Goldstein, Stuart L et al. (2018) Assessment of a renal angina index for prediction of severe acute kidney injury in critically ill children: a multicentre, multinational, prospective observational study. Lancet Child Adolesc Health 2:112-120
Jotwani, Vasantha; Scherzer, Rebecca; Glidden, David V et al. (2018) Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals. J Acquir Immune Defic Syndr 78:169-174
Valiente-Alandi, IƱigo; Potter, Sarah J; Salvador, Ane M et al. (2018) Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure. Circulation 138:1236-1252
Jotwani, Vasantha; Katz, Ronit; Ix, Joachim H et al. (2018) Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders. Am J Kidney Dis 72:205-213

Showing the most recent 10 out of 124 publications